Detalhe da pesquisa
1.
Factors associated with immunological non-response after ART initiation: a retrospective observational cohort study.
BMC Infect Dis
; 24(1): 138, 2024 Jan 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38287246
2.
Characteristics and clinical significance of plasma IL-18, sCD14, and sCD163 levels in patients with HIV-1 infection.
J Med Virol
; 95(1): e28223, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36229975
3.
[Semen quality and HIV RNA level in HIV/AIDS male patients after treated by highly active antiretroviral therapy].
Zhonghua Nan Ke Xue
; 24(5): 414-418, 2018 May.
Artigo
em Zh
| MEDLINE | ID: mdl-30171756
4.
Early on-treatment plasma interleukin-18 as a promising indicator for long-term virological response in patients with HIV-1 infection.
Front Med (Lausanne)
; 10: 1170208, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37384047
5.
Incidence and factors associated with hepatitis B surface antigen seroclearance in patients co-infected with HBV/HIV during antiretroviral therapy in Guangdong, China.
Chin Med J (Engl)
; 136(22): 2686-2693, 2023 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37881959
6.
Transcriptome analysis of CD4+ T cells from HIV-infected individuals receiving ART with LLV revealed novel transcription factors regulating HIV-1 promoter activity.
Virol Sin
; 38(3): 398-408, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36907331
7.
HIV-infected patients rarely develop invasive fungal diseases under good immune reconstitution after ART regardless high prevalence of pathogenic filamentous fungi carriage in nasopharynx/oropharynx.
Front Microbiol
; 13: 968532, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36406455
8.
Persistently low CD4 cell counts are associated with hepatic events in HCV/HIV coinfected patients: data from the national free antiretroviral treatment program of China.
Chin Med J (Engl)
; 135(22): 2699-2705, 2022 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36574222
9.
[The therapeutic effects of highly active anti-retroviral therapy in 74 treatment-naive patients with AIDS in China].
Zhonghua Nei Ke Za Zhi
; 50(1): 59-62, 2011 Jan.
Artigo
em Zh
| MEDLINE | ID: mdl-21418892
10.
Antiretroviral Long-Term Efficacy and Resistance of Lopinavir/Ritonavir Plus Lamivudine in HIV-1-Infected Treatment-Naïve Patients (ALTERLL): 144-Week Results of a Randomized, Open-Label, Non-Inferiority Study From Guangdong, China.
Front Pharmacol
; 11: 569766, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33841131
11.
Dual therapy with lopinavir/ritonavir plus lamivudine could be a viable alternative for antiretroviral-therapy-naive adults with HIV-1 infection regardless of HIV viral load or subgenotype in resource-limited settings: A randomised, open-label and non-inferiority study from China.
Indian J Med Microbiol
; 36(4): 513-516, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30880698
12.
The Double Burdens of Mental Health Among AIDS Patients With Fully Successful Immune Restoration: A Cross-Sectional Study of Anxiety and Depression in China.
Front Psychiatry
; 9: 384, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30197608